Keyphrases
Available Technology
9%
Biological Cells
7%
Biological Inference
9%
Biological Knowledge
14%
Biological Validation
9%
Brain Glioma
28%
Bulk Samples
23%
Bulk Tissue
14%
Bulk Transcriptome
14%
Cancer Diagnosis
14%
Cancer Genome Atlas
9%
Cancer Omics Data
28%
Cancer Patients
14%
Cancer Subtypes
7%
Cell Cycle Machinery
9%
Cell Mixture
9%
Cell Population
14%
Cell Signaling Networks
14%
Cell Subtypes
14%
Cellular Heterogeneity
9%
Cellular Level
14%
Clinical Issues
14%
Clinical Parameters
9%
Clinically Meaningful Outcomes
7%
Coding RNA
9%
COL6A2
9%
Complex Cell
9%
Complex DNA Mixtures
28%
Complex Samples
9%
Confounder Adjustment
9%
CRISPR Interference (CRISPRi)
28%
CRISPR-associated Protein 9
9%
Cyclin-dependent Kinase 4 (CDK4)
9%
Cytokine Stimulation
28%
Data Preparation
9%
Data Preprocessing
9%
Data-driven Methods
9%
Deconvolution
28%
Deconvolution Method
18%
Deconvolution Visualization
28%
Different Datasets
7%
DNA Methylation Data
28%
DNA Methylation Profile
9%
DNA Methylation Profiling
9%
DNA Methylome
9%
DNA Repair Pathways
9%
Exon Junction
14%
Expression Data
14%
Factorization Method
7%
Feature Selection
9%
Feature Selection Methods
14%
Gene Expression
14%
Gene Isoforms
28%
Genotoxic Agents
9%
Genotoxic Damage
9%
Genotype Interactions
9%
Graphical User Interface
9%
Group-specific
9%
Harmonized Approach
9%
Health Avatar
28%
Heterogeneous Tumors
28%
High Fold
14%
High-throughput Genetic Screen
9%
Human Development
9%
Human Disease
9%
Inefficacy
9%
International Cooperative Ataxia Rating Scale (ICARS)
23%
Lung Cancer
9%
Massive Parallelism
14%
Matrix Factorization
7%
Methylation
9%
Methylation Changes
9%
Methylome
9%
Microarray
14%
MiRNA Target Genes
9%
MiRNome
28%
Multiple Parameters
9%
Multiple Tissues
9%
Mutual Dependence
7%
Neoplastic Cells
14%
Network Datasets
9%
Non-small Cell Lung Cancer (NSCLC)
14%
NrCAM
9%
Nuclear Localization
9%
Orthotopic Xenograft
28%
Parallel Consensus
7%
Parallel Technique
14%
Pathway Knowledge
9%
Patient Characteristics
7%
Patient Classification
14%
Patient Cohort
9%
Patient-derived Organoids
28%
PIWI-interacting RNA (piRNA)
9%
Pooled Screening
9%
Primary Control
7%
Process Outcomes
28%
Publicly Available Data
14%
R Shiny
9%
Reference Deconvolution
28%
Research Discovery
14%
Risk Score
7%
Signal Deconvolution
7%
Skin Tissue
14%
Specific Vulnerability
9%
Stromal Cells
14%
Stromal Tumor
9%
Surgical Mask
9%
Target Gene Prediction
9%
Targetome
9%
Technical Bias
21%
Technology-based
9%
Therapeutic Target
14%
Three-stage Protocol
9%
Tissue Analysis
14%
Transcriptome
28%
Transcriptome-wide
9%
Transcriptomic Response
14%
Tumor
28%
Tumor Biology
7%
Tumor Samples
28%
Tumor-infiltrating Immune Cells
9%
Unsupervised Method
7%
Zinc Finger
18%
Biochemistry, Genetics and Molecular Biology
Alpha Thalassemia/Mental Retardation X-Linked
9%
Angiogenesis
9%
Biological Functions
9%
Biological Phenomena and Functions Concerning the Entire Organism
28%
Blood Brain Barrier
14%
Cancer Model
9%
Candidate Gene
9%
Cell Proliferation
9%
Clinical Trial
9%
Clonal Evolution
9%
COL6A2
14%
Colon
5%
Complex System
5%
CRISPR
28%
CRISPR/Cas9
9%
Cyclin Dependent Kinase Inhibitor 2A
9%
Cyclin-Dependent Kinase
9%
Cytokine
28%
Dimensionality Reduction
5%
Drug Response
9%
Epidermal Growth Factor Receptor
28%
Epigenetics
9%
Essential Gene
14%
Exon
28%
Feature Extraction
28%
Functional Magnetic Resonance Imaging
5%
Gene Expression
37%
Gene Expression Profiling
28%
Gene Function
9%
Genetic Screen
9%
Genetic Transcription
14%
Genetics
18%
Genotyping
9%
IDH1
18%
Immune Response
9%
Immunocompetent Cell
9%
Isoform
28%
Messenger RNA
43%
Methylome
5%
MicroRNA
37%
Non-Coding RNA
7%
Nuclear Protein
14%
Patient Coding
28%
Piwi-Interacting RNA
7%
Platelet Derived Growth Factor Receptor Alpha
9%
Principal Component Analysis
5%
Promoter Region
23%
Protein Complexes
14%
Proteome
5%
RNA
28%
RNA Interference
28%
STAT1
28%
STAT3
28%
Stromal Cell
28%
Tamsulosin
37%
Transcriptome
100%
Transcriptomics
30%
Vascularization
9%
Zinc Finger Motif
28%
Medicine and Dentistry
Alkylating Antineoplastic Agent
10%
Biopsy Technique
14%
Blood Brain Barrier
5%
Cell Cycle
28%
Cell DNA
7%
Cellular Model
5%
DNA A
28%
DNA Damage Response
14%
DNA Repair
28%
Epidermal Growth Factor Receptor
10%
Ganglioglioma
28%
Gene Expression
21%
Gene Expression Profiling
28%
Genetic Transcription
5%
Glioblastoma
59%
Intracranial Tumor
5%
Neoplasm
28%
Nuclear Protein
5%
Organoid
28%
Primary Tumor
10%
Progression Free Survival
7%
Promoter Region
9%
Protein Complex
5%
Radiation Therapy
21%
Recurrent Disease
7%
Synapsin II
28%
Systemic Therapy
5%
Temozolomide
21%
Tumor Cell
5%
Tumor Invasion
5%
Tumor Recurrence
10%
Xenograft
28%